Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

Robotic-Assisted Bronchoscopy-Guided Synchronous Biopsy and Radiofrequency Ablation for Pulmonary Nodules

NCT07545057 · Shanghai Chest Hospital · Updated 28 April 2026

What is being tested
Robotic-assisted bronchoscopy-guided synchronous biopsy and radiofrequency ablation for pulmonary nodules
For
Pulmonary Nodules
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 100 years. About 76 people. The full rules are on the registry page.
Where
China
When
Starts or started 1 May 2026, ends 31 Dec 2027. Registered 22 April 2026.
Results
None posted yet.

In the researchers' words

This is a prospective, single-arm, open-label clinical study. The primary study objective is to evaluate the feasibility of synchronous biopsy and radiofrequency ablation for pulmonary nodules under robotic-assisted bronchoscopy.
ClinicalTrials.gov, NCT07545057

Sites

  • Shanghai Chest HospitalShanghai, China